Birdwatch Note
2023-04-19 01:13:17 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The present bivalent vaccine was approved based on a study of 8 mice https://www.nature.com/articles/s41591-022-02092-8 It has also been widely reported that the bivalent vaccines are no more efficacious than the original https://www.bloomberg.com/news/articles/2022-10-25/new-boosters-from-moderna-and-pfizer-aren-t-better-than-old-ones-study-shows
Written by A7826FFB1C43F7DB70738BD249262EF1CD8C03349DA303F2082E0077AC43A9CC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1648315662559748096
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1648494944917630976
- noteId - 1648494944917630976
- participantId -
- noteAuthorParticipantId - A7826FFB1C43F7DB70738BD249262EF1CD8C03349DA303F2082E0077AC43A9CC Participant Details
- createdAtMillis - 1681866797081
- tweetId - 1648315662559748096
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The present bivalent vaccine was approved based on a study of 8 mice https://www.nature.com/articles/s41591-022-02092-8 It has also been widely reported that the bivalent vaccines are no more efficacious than the original https://www.bloomberg.com/news/articles/2022-10-25/new-boosters-from-moderna-and-pfizer-aren-t-better-than-old-ones-study-shows
Note Ratings
rated at | rated by | |
2023-05-09 13:12:28 -0500 | Rating Details | |
2023-04-19 05:01:45 -0500 | Rating Details | |
2023-04-18 20:32:10 -0500 | Rating Details | |
2023-04-19 02:01:25 -0500 | Rating Details | |
2023-04-18 20:40:13 -0500 | Rating Details | |
2023-04-19 01:03:35 -0500 | Rating Details | |
2023-04-18 22:07:11 -0500 | Rating Details | |
2023-04-18 20:15:10 -0500 | Rating Details | |
2023-04-18 20:35:53 -0500 | Rating Details | |
2023-04-18 22:52:07 -0500 | Rating Details | |
2023-04-19 01:25:37 -0500 | Rating Details | |
2023-04-18 21:27:37 -0500 | Rating Details | |
2023-04-19 09:07:49 -0500 | Rating Details | |
2023-04-19 01:30:42 -0500 | Rating Details | |
2023-04-19 00:28:45 -0500 | Rating Details | |
2023-04-19 03:17:02 -0500 | Rating Details | |
2023-04-18 21:20:14 -0500 | Rating Details | |
2023-04-18 21:58:12 -0500 | Rating Details | |
2023-04-27 03:24:06 -0500 | Rating Details | |
2023-04-18 21:36:47 -0500 | Rating Details | |
2023-04-19 01:34:18 -0500 | Rating Details | |
2023-04-19 00:05:22 -0500 | Rating Details | |
2023-04-18 21:11:18 -0500 | Rating Details | |
2023-04-18 20:59:02 -0500 | Rating Details | |
2023-04-19 11:36:39 -0500 | Rating Details | |
2023-04-19 03:02:23 -0500 | Rating Details | |
2023-04-20 03:44:32 -0500 | Rating Details | |
2023-04-18 21:06:42 -0500 | Rating Details | |
2023-04-18 22:31:00 -0500 | Rating Details | |
2023-04-19 08:06:56 -0500 | Rating Details | |
2023-04-18 21:52:15 -0500 | Rating Details | |
2023-04-18 20:41:16 -0500 | Rating Details | |
2023-04-19 02:20:13 -0500 | Rating Details | |
2023-04-19 05:01:45 -0500 | Rating Details | |
2023-04-18 20:32:10 -0500 | Rating Details | |
2023-04-19 02:01:25 -0500 | Rating Details | |
2023-04-18 20:40:13 -0500 | Rating Details | |
2023-04-19 01:03:35 -0500 | Rating Details | |
2023-04-18 22:07:11 -0500 | Rating Details | |
2023-04-18 20:15:10 -0500 | Rating Details | |
2023-04-18 20:35:53 -0500 | Rating Details | |
2023-04-18 22:52:07 -0500 | Rating Details | |
2023-04-19 01:25:37 -0500 | Rating Details | |
2023-04-18 21:27:37 -0500 | Rating Details | |
2023-04-19 09:07:49 -0500 | Rating Details | |
2023-04-19 01:30:42 -0500 | Rating Details | |
2023-04-19 00:28:45 -0500 | Rating Details | |
2023-04-19 03:17:02 -0500 | Rating Details | |
2023-04-18 21:20:14 -0500 | Rating Details | |
2023-04-18 21:58:12 -0500 | Rating Details | |
2023-04-27 03:24:06 -0500 | Rating Details | |
2023-04-18 21:36:47 -0500 | Rating Details | |
2023-04-19 01:34:18 -0500 | Rating Details | |
2023-04-19 00:05:22 -0500 | Rating Details | |
2023-04-18 21:11:18 -0500 | Rating Details | |
2023-04-18 20:59:02 -0500 | Rating Details | |
2023-04-19 11:36:39 -0500 | Rating Details | |
2023-04-19 03:02:23 -0500 | Rating Details | |
2023-04-20 03:44:32 -0500 | Rating Details | |
2023-05-09 13:12:28 -0500 | Rating Details | |
2023-04-18 21:06:42 -0500 | Rating Details | |
2023-04-18 22:31:00 -0500 | Rating Details | |
2023-04-19 08:06:56 -0500 | Rating Details | |
2023-04-18 21:52:15 -0500 | Rating Details | |
2023-04-18 20:41:16 -0500 | Rating Details | |
2023-04-19 02:20:13 -0500 | Rating Details |